Early mortality in children with advanced mature b-cell malignancies in a middle-income country

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 7, 2012, Pages

  Cervio, Carolina ^a   Barsotti, Dario ^a   Ibanez, Juan ^a   Paganini, Hugo ^a   Sara Felice, María ^a   Chantada, Guillermo L ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

B cell malignancies; developing countries; survival; toxicity

Indexed keywords

CREATININE; CYTARABINE; ETOPOSIDE; LACTATE DEHYDROGENASE; METHOTREXATE; PHOSPHATE;

ADOLESCENT; ARTICLE; B NONHODGKIN LYMPHOMA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER STAGING; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DEVELOPING COUNTRY; DRUG MEGADOSE; FEMALE; GASTROINTESTINAL TOXICITY; HOSPITAL ADMISSION; HUMAN; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHODGKIN LYMPHOMA; OROINTESTINAL TOXICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SEPSIS; STEVENS JOHNSON SYNDROME; STOMACH PERFORATION;

ADOLESCENT; ARGENTINA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84866895892     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31826226b1     Document Type: Article

References (26)

1. Reiter A. Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematol Am Soc Hematol Educ Program. 2007; 285-296.
2. Patte C, Auperin A, Michon J, et al. The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lympho-mas and L3 leukemia. Blood. 2001;97:3370-3379.
3. Cairo MS, Sposto R, Perkins SL, et al. Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience. Br J Haematol. 2003;120: 660-670.
4. Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109:2736-2743.
5. Wrobel G, Mauguen A, Rosolen A, et al. Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: Report of the ALCL99 randomised trial. Pediatr Blood Cancer. 2011;56:1071-1077.
6. Hesseling PB, Molyneux E, Tchintseme F, et al. Treating Burkitt's lymphoma in Malawi, Cameroon, and Ghana. Lancet Oncol. 2008;9:512-513.
7. Hesseling P, Broadhead R, Mansvelt E, et al. The 2000 Burkitt lymphoma trial in Malawi. Pediatr Blood Cancer. 2005;44:245-250.
8. Traore F, Coze C, Atteby JJ, et al. Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer. 2011;56:70-76.
9. Howard SC, Ortiz R, Baez LF, et al. Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)\part II. Pediatr Blood Cancer. 2007;48:486-490.
10. Klumb CE, Schramm MT, De Resende LM, et al. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol. 2004;26:462-468.
11. Acquatella G, Insausti CL, Garcia R, et al. Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol. Pediatr Blood Cancer. 2004;43:580-586.
12. Muller J, Csoka M, Jakab Z, et al. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols. Pediatr Blood Cancer. 2008; 50:633-635.
13. Kutluk T, Varan A, Akyuz C, et al. Clinical characteristics and treatment results of LMB/LMT regimen in children with non-Hodgkin's lymphoma. Cancer Invest. 2002;20:626-633.
14. Chantada G, Casak S, Alderete D, et al. Treatment of B-cell malignancies in children with a modified BFM-NHL 90 protocol in Argentina. Med Pediatr Oncol. 2003;41:488-490.
15. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood. 1999;94:3294-3306.
16. Murphy SB, Fairclough DL, Hutchison RE, et al. Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution. J Clin Oncol. 1989;7:186-193.
17. Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004;127:3-11.
18. Woessmann W, Seidemann K, Mann G, et al. The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood. 2005; 105:948-958.
19. Harif M, Barsaoui S, Benchekroun S, et al. Treatment of B-cell lymphoma with LMB modified protocols in Africa\report of the French-African Pediatric Oncology Group (GFAOP). Pediatr Blood Cancer. 2008;50:1138-1142.
20. Moe PJ, Seip M. High dose methotrexate in acute lymphocytic leukemia in childhood. Acta Paediatr Scand. 1978;67:265-268.
21. Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood. 2007;109:2773-2780.
22. Seidemann K, Meyer U, Jansen P, et al. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Klin Padiatr. 1998;210:279-284.
23. Patte C, Sakiroglu C, Ansoborlo S, et al. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol. Ann Oncol. 2002;13:789-795.
24. Wossmann W, Schrappe M, Meyer U, et al. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Ann Hematol. 2003;82:160-165.
25. Rivera-Luna R, Martinez-Guerra G, Martinez-Avalos A, et al. Treatment of non-Hodgkin's lymphoma in Mexican children. The effectiveness of chemotherapy during malnutrition. Am J Pediatr Hematol Oncol. 1987;9:356-366.
26. Patte C, Laplanche A, Bertozzi AI, et al. Granulocyte colony-stimulating factor in induction treatment of children with non-Hodgkin's lymphoma: a randomized study of the French Society of Pediatric Oncology. J Clin Oncol. 2002;20:441-448.